PROTAC<sup>®</sup> technology and potential for its application in infection control
Objectives. To describe the pharmaceutical technology of controlled degradation of protein molecules (PROTAC®, Proteolysis Targeting Chimera), approaches to the design of the PROTAC® molecule, methods of ligand and linker selection and synthesis, as well as the application of this technology in deal...
Saved in:
| Main Authors: | M. A. Zakharova, M. V. Chudinov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
MIREA - Russian Technological University
2024-07-01
|
| Series: | Тонкие химические технологии |
| Subjects: | |
| Online Access: | https://www.finechem-mirea.ru/jour/article/view/2086 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PROTAC-Based Antivirals for Respiratory Viruses: A Novel Approach for Targeted Therapy and Vaccine Development
by: Amith Anugu, et al.
Published: (2025-07-01) -
Unraveling chain specific ubiquitination in cells using tandem ubiquitin binding entities
by: Muhammad Shahzad Ali, et al.
Published: (2025-07-01) -
Identification of suitable target/E3 ligase pairs for PROTAC development using a rapamycin-induced proximity assay (RiPA)
by: Bikash Adhikari, et al.
Published: (2024-12-01) -
Ubiquitination of transcription factors in cancer: unveiling therapeutic potential
by: Dongha Kim, et al.
Published: (2025-08-01) -
Unraveling the Engagement of Kinases to CRBN Through a Shared Structural Motif to Optimize PROTACs Efficacy
by: Serena Rosignoli, et al.
Published: (2025-02-01)